About KDRA
Overview of KDRA
In 1986 Korea Drug Research Association(KDRA), Korean Pharmaceutical Innovators’ Group was established as non-profit organization to cope with the introduction of a new product patent system based on the law for fostering industrial technology association and represents R&D based pharmaceutical & biotech industry in Korea.
From its establishment KDRA has been working for the development of Korean Pharmaceutical & Biotech industries promoting the industrial technologies in pharmaceutical & biotech fields. For this KDRA has been participating in and leading biotech R&D policy-making, strategy formulating and improvement of advanced R&D systems. KDRA has since 1986 engaged in mid-and long-term nat'l R&D programs, drived and managed various kinds of R&D programs including those sponcered by the government in several innovation areas; NCE, NME, API, herbal medicine, New Indication, New Route of Administration, New Formulation, New Ester, Salt or Other Non-covalent Derivative, New Dosage Form or Strength, Combination Product etc.
KDRA has also been working in business partnering and technology transfer & licensing between the pharmaceutical & biotech industries, academic and public research organizations domestically and internationally. For these activities, KDRA has since 2002 been organizing annual business partnering event, InterBiz Bio-Partnering & Investment Forum, a key conference for technology transfer & collaboration with average 100 domestic & international companies & orgs.
To provide the industry with additional opportunities for domestic & global business development, KDRA has established and is managing a distinctive subsidiary organization, PTBC(PharmaTech Business Center) for providing services in technology transfer, licensing and R&D collaboration activities between KDRA members and domestic & international partners.
To cope with the global mega trends and environmental changes surrounding the pharmaceutical industry in several areas; market, technology, regulation and business, KDRA has since 1994 established several subsidiary associations; Association of API Development Professionals(1994), Association of Regulatory Affairs Professionals(2006), Association of Pharmaceutical Research Analysis(2008) and Korea Herbal Medicine Association(2011). Additionally to provide theoretical & statistical approaches to the industry of its importance and contribution to the promotion of national healthcare, reduction of healthcare budget and control & management of life threatening, chronic and intractable diseases of the population, KDRA has in 2010 established Innovation Policy Research Center(InnoPol), and has established Korea Business Development Professionals' group(K-BD Group) in 2017 to promote open innovation & investment between pharma&biotech companies, bio-startups, academic organizations etc.